Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-12

Clinical Trial Update: Comparison of Efficacy and Safety Between FOLFOX-6 and CAPOX in Metastatic Colorectal Carcinoma [NA]

View source ↗

Summary

A clinical trial comparing FOLFOX-6 and CAPOX regimens for metastatic colorectal cancer is currently enrolling by invitation at Allama Iqbal Medical College.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • CAPOX (capecitabine + oxaliplatin)
  • Capecitabine (capecitabine)
  • FOLFOX-6
  • Leucovorin (folinic acid)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Allama Iqbal Medical College | Conditions: Metastatic Colorectal Carcinoma (mCRC) | NA | Status: ENROLLING_BY_INVITATION